StockData
ELI LILLY & Co logo

ELI LILLY & Co (LLY) operating KPIs

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)

Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%

Eli Lilly revenue ($M) ($M)

Form 10-Q / 10-K Consolidated Statements of Operations (Postgres DB)

Latest, Q2 2026
22,974
Period ended Jun 30, 2026
Change on a year earlier
+47.7%
15,558 in Q2 2025
History
69 quarters
Since Q2 2008
Sources
57
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedRevenue ($M) ($M)Year on yearSource
Q2 2026Jun 30, 202622,974+47.7%Form 10-Q (filed 2026-08-05) ↗
Q1 2026Mar 31, 202619,799+55.5%Form 10-Q (filed 2026-04-30) ↗
Q4 2025Dec 31, 202519,292+42.6%Form 10-K (filed 2026-02-12) ↗
Q3 2025Sep 30, 202517,601+53.9%Form 10-Q (filed 2025-10-30) ↗
Q2 2025Jun 30, 202515,558+37.6%Form 10-Q (filed 2026-08-05) ↗
Q1 2025Mar 31, 202512,729+45.2%Form 10-Q (filed 2026-04-30) ↗
Q4 2024Dec 31, 202413,533+44.7%Form 10-K (filed 2026-02-12) ↗
Q3 2024Sep 30, 202411,439+20.4%Form 10-Q (filed 2024-10-30) ↗
Q2 2024Jun 30, 202411,303+36.0%Form 10-Q (filed 2024-08-08) ↗
Q1 2024Mar 31, 20248,768+26.0%Form 10-Q (filed 2024-04-30) ↗
Q4 2023Dec 31, 20239,353+28.1%Form 10-K (filed 2026-02-12) ↗
Q3 2023Sep 30, 20239,499+36.8%Form 10-Q (filed 2023-11-02) ↗
Q2 2023Jun 30, 20238,312+28.1%Form 10-Q (filed 2023-08-08) ↗
Q1 2023Mar 31, 20236,960-10.9%Form 10-Q (filed 2023-04-27) ↗
Q4 2022Dec 31, 20227,302-8.7%Form 10-K (filed 2023-02-22) ↗
Q3 2022Sep 30, 20226,942+2.5%Form 10-Q (filed 2022-11-01) ↗

Breakdown

What makes up revenue ($m)

Cite this data

StockData. (2026). Eli Lilly Revenue ($M) ($M), quarterly Q2 2008–Q2 2026 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/fin_rev

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.